Subscribe To
Xencor to present preclinical data from xmab® cytokine programs at the american association for cancer research (aacr) annual meeting 2022
MONROVIA, Calif.--(BUSINESS WIRE)--Xencor, Inc. (NASDAQ: XNCR), a clinical-stage biopharmaceutical comp...
March 8, 2022, 4:31 pm
Regeneron, biontech to test experimental combination therapy for lung cancer
BioNTech SE BNTX, -1.36% and Regeneron pharmaceuticals Inc. REGN, -0.58% said they plan to test an expe...
March 8, 2022, 9:16 am
Diamedica therapeutics to report fourth quarter 2021 financial results and provide a business update march 15, 2022
MINNEAPOLIS--(BUSINESS WIRE)--DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical...
March 8, 2022, 8:13 am
Inhibikase therapeutics to present phase 1/1b clinical data at the upcoming ad/pd™ alzheimer's & parkinson's diseases conference
BOSTON and ATLANTA, March 8, 2022 /PRNewswire/ -- Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (Inhibikase), a clinical-stage ...
March 8, 2022, 8:00 am
Should you invest in the ishares u.s. pharmaceuticals etf (ihe)?
Sector ETF report for IHE...
March 8, 2022, 7:32 am
Eagle pharmaceuticals, inc. (egrx) ceo scott tarriff on q4 2021 results - earnings call transcript
Eagle pharmaceuticals, Inc. (EGRX) CEO Scott Tarriff on Q4 2021 Results - Earnings Call Transcript...
March 7, 2022, 2:02 pm
Eagle pharmaceuticals, inc. (egrx) ceo scott tarriff on q4 2021 results - earnings call transcript
Eagle pharmaceuticals, Inc. (EGRX) CEO Scott Tarriff on Q4 2021 Results - Earnings Call Transcript...
March 7, 2022, 2:02 pm
Eagle pharmaceuticals, inc. (egrx) ceo scott tarriff on q4 2021 results - earnings call transcript
Eagle pharmaceuticals, Inc. (EGRX) CEO Scott Tarriff on Q4 2021 Results - Earnings Call Transcript...
March 7, 2022, 2:02 pm
Taysha gene therapies gets a 'thumbs up'
Shares of biopharmaceutical concern Taysha Gene Therapies, Inc. (TSHA) have lost over 70% of their valu...
March 7, 2022, 1:50 pm
Taysha gene therapies gets a 'thumbs up'
Shares of biopharmaceutical concern Taysha Gene Therapies, Inc. (TSHA) have lost over 70% of their valu...
March 7, 2022, 1:50 pm
Taysha gene therapies gets a 'thumbs up'
Shares of biopharmaceutical concern Taysha Gene Therapies, Inc. (TSHA) have lost over 70% of their valu...
March 7, 2022, 1:50 pm
Eagle pharmaceuticals (egrx) lags q4 earnings and revenue estimates
Eagle pharmaceuticals (EGRX) delivered earnings and revenue surprises of -2.30% and 10.57%, respectivel...
March 7, 2022, 9:45 am
Eagle pharmaceuticals (egrx) lags q4 earnings and revenue estimates
Eagle pharmaceuticals (EGRX) delivered earnings and revenue surprises of -2.30% and 10.57%, respectivel...
March 7, 2022, 9:45 am
Eagle pharmaceuticals (egrx) lags q4 earnings and revenue estimates
Eagle pharmaceuticals (EGRX) delivered earnings and revenue surprises of -2.30% and 10.57%, respectivel...
March 7, 2022, 9:45 am
Ventyx biosciences to participate in the barclays global healthcare conference
ENCINITAS, Calif., March 07, 2022 (GLOBE NEWSWIRE) -- Ventyx Biosciences, Inc. (Nasdaq: VTYX) (“Ventyx” or the “Company”), a clinical-stage bi...
March 7, 2022, 8:00 am
Ventyx biosciences to participate in the barclays global healthcare conference
ENCINITAS, Calif., March 07, 2022 (GLOBE NEWSWIRE) -- Ventyx Biosciences, Inc. (Nasdaq: VTYX) (“Ventyx” or the “Company”), a clinical-stage bi...
March 7, 2022, 8:00 am
Ventyx biosciences to participate in the barclays global healthcare conference
ENCINITAS, Calif., March 07, 2022 (GLOBE NEWSWIRE) -- Ventyx Biosciences, Inc. (Nasdaq: VTYX) (“Ventyx” or the “Company”), a clinical-stage bi...
March 7, 2022, 8:00 am
Ani pharmaceuticals to discuss fourth quarter and full year 2021 financial results on march 15, 2022
BAUDETTE, Minn.--(BUSINESS WIRE)--ANI pharmaceuticals, Inc. (“ANI” or the “Company”) (NASDAQ: A...
March 7, 2022, 6:50 am
Ani pharmaceuticals to discuss fourth quarter and full year 2021 financial results on march 15, 2022
BAUDETTE, Minn.--(BUSINESS WIRE)--ANI pharmaceuticals, Inc. (“ANI” or the “Company”) (NASDAQ: A...
March 7, 2022, 6:50 am
Ani pharmaceuticals to discuss fourth quarter and full year 2021 financial results on march 15, 2022
BAUDETTE, Minn.--(BUSINESS WIRE)--ANI pharmaceuticals, Inc. (“ANI” or the “Company”) (NASDAQ: A...
March 7, 2022, 6:50 am